X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
AMAR REMEDIES Fact Sheet, AMAR REMEDIES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES Fact Sheet   (AMAD)

Here is the latest financial fact sheet of AMAR REMEDIES. For more details, see the AMAR REMEDIES quarterly results and AMAR REMEDIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

AMAR REMEDIES Price History

Price Rs 6.1
Mkt Cap Rs m 159
Vol '000 139.7
P/E X -0.5
P/CF X 0.3
EPS (TTM) Rs -12.0
% ch % 0.5
No. of shares m 26.16
% ch week % -7.6
% ch 1-mth % -18.5
% ch 12-mth % -82.7
52 week H/L Rs 48.0/5.5
(As on Dec 11, 2013 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AMAR REMEDIES Financials

No. of Mths
Year Ending
12
Jun-08
12
Jun-09
*
12
Jun-10
*
12
Jun-11
*
12
Jun-12
*
5-Yr Chart
Click to enlarge
AMAR REMEDIES EQUITY SHARE DATA
High Rs583979171164 
Low Rs2113247586 
Sales per share (Unadj.) Rs114.0141.1187.6228.2261.6 
Earnings per share (Unadj.) Rs8.310.212.614.917.4 
Diluted earnings per shareRs8.310.212.614.917.4 
Cash flow per share (Unadj.) Rs9.212.916.619.222.3 
Dividends per share (Unadj.) Rs01.001.001.000 
Adj. dividends per shareRs0.001.001.001.000.00 
Dividend yield (eoy) %03.81.90.80 
Book value per share (Unadj.) Rs47.656.868.383.2100.7 
Adj. book value per shareRs47.656.868.383.2100.7 
Shares outstanding (eoy) m26.1626.1626.1626.1626.16 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x0.30.20.30.50.5 
Avg P/E ratio x4.72.64.18.27.2 
P/CF ratio (eoy) x4.32.03.16.45.6 
Price / Book Value ratio x0.80.50.81.51.2 
Dividend payout %09.88.06.70 
Avg Mkt Cap Rs m1,0336801,3473,2183,270 
No. of employees `000NANANANANA 
Total wages/salary Rs m8380108128163 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
AMAR REMEDIES INCOME DATA
Net Sales Rs m2,9823,6924,9085,9706,844 
Other income Rs m319111021 
Total revenues Rs m2,9853,7114,9195,9806,865 
Gross profit Rs m3564756868331,131 
Depreciation Rs m2272104110128 
Interest Rs m76124208274398 
Profit before tax Rs m261298385459626 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m0000-50 
Tax Rs m43325668121 
Profit after tax Rs m218266329391455 
Gross profit margin %11.912.914.014.016.5 
Effective tax rate %16.510.714.514.819.3 
Net profit margin %7.37.26.76.56.6 
AMAR REMEDIES BALANCE SHEET DATA
Current assets Rs m1,2551,7622,4713,3344,904 
Current liabilities Rs m2834766012,4703,581 
Net working cap to sales %32.634.838.114.519.3 
Current ratio x4.43.74.11.31.4 
Inventory Days Days60798593124 
Debtors Days Days83818387100 
Net fixed assets Rs m8401,0821,1621,3821,689 
Share capital Rs m262262262262262 
"Free" reserves Rs m1,0081,2441,5421,9032,358 
Net worth Rs m1,2451,4851,7882,1772,635 
Long term debt Rs m423730275507 
Total assets Rs m2,0952,8463,6334,9286,862 
Interest coverage x4.43.42.92.72.6 
Debt to equity ratio x0000.10.2 
Sales to assets ratio x1.41.31.41.21.0 
Return on assets %14.013.714.813.512.4 
Return on equity %17.517.918.418.017.3 
Return on capital %26.227.732.629.931.0 
Exports to sales %1.33.51.71.34.0 
Imports to sales %00000 
Exports (fob) Rs m381298180273 
Imports (cif) Rs m00000 
Fx inflow Rs m381298180273 
Fx outflow Rs m715412 
Net fx Rs m311147779271 
AMAR REMEDIES CASH FLOW
From Operations Rs m 20 25 -110 -18 -313 
From Investments Rs m -48 -314 -186 -471 -489 
From Financial Activity Rs m 29 295 328 571 769 
Net Cashflow Rs m 0 6 31 82 -33 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 9.2%
FIIs 0.0%
ADR/GDR 0.0%
Free float 65.3%
Shareholders 13,061
Pledged promoter(s) holding 99.7%
 

Company Information

REGD OFF B-G01, Marathon Innova, Ganpatrao Kadam Marg, Lower Parel, Mumbai-13
E-MAIL investors@amarremedies.com WEB www.amarremedies.com
TELEPHONE (022) 6556 8091 FAX NA
SECTOR CONSUMER PRODUCTS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Shyam C. Agrawal & Co.
CHM: Pravin N. Shah COMP SEC: Jagdish Nagpal YEAR OF INC: 1984 BSE CODE: 532664 FV (Rs): 10 DIV YIELD (%): -

More Consumer Products Company Fact Sheets:   ALEMBIC LTD  VENUS REMEDIES  PLETHICO PHARMA  AUROBINDO PHARMA  UNICHEM LAB  

Compare AMAR REMEDIES With:   ALEMBIC LTD  VENUS REMEDIES  PLETHICO PHARMA  AUROBINDO PHARMA  UNICHEM LAB  

Compare AMAR REMEDIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMAR REMEDIES

AMAR REMEDIES - BAJAJ CORP COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS